Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about oligodendrocytes: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet. View on Wiki →
| Cell Type | oligodendrocytes |
| Definition | <table class="infobox infobox-cell"> |
| Key Markers | TAU, myelin, HSPA1A, SMS2, GPR37, PIEZO1, GBA1, Prosaposin |
| Key Pathways | Dna Damage Response, sphingolipid metabolism, complement cascade, pyroptosis, unfolded protein response |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, aging, Alzheimer's disease, Alzheimer'S Disease, Vascular Dementia |
| Linked Hypotheses | 112 hypotheses |
Knowledge base pages for this entity
graph TD
oligodendrocytes["oligodendrocytes"] -->|"produces"| myelin["myelin"]
style myelin fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
oligodendrocytes["oligodendrocytes"] -->|"associated"| multiple_sclerosis["multiple sclerosis"]
style multiple_sclerosis fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
oligodendrocytes["oligodendrocytes"] -->|"associated"| neurodegeneration["neurodegeneration"]
style neurodegeneration fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
oligodendrocytes["oligodendrocytes"] -->|"activates"| neuroinflammation["neuroinflammation"]
style neuroinflammation fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
oligodendrocytes["oligodendrocytes"] -->|"involved in"| myelin_dysfunction["myelin dysfunction"]
style myelin_dysfunction fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
oligodendrocytes["oligodendrocytes"] -->|"causes"| Parkinson_s_disease["Parkinson's disease"]
style Parkinson_s_disease fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
oligodendrocytes["oligodendrocytes"] -->|"activates"| phagocytosis["phagocytosis"]
style phagocytosis fill:#1a2a3a,stroke:#ffd54f,stroke-width:1px,color:#fff
neurodegeneration_1["neurodegeneration"] -->|"affects"| oligodendrocytes["oligodendrocytes"]
style neurodegeneration_1 fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
multiple_sclerosis_2["multiple sclerosis"] -->|"affects"| oligodendrocytes["oligodendrocytes"]
style multiple_sclerosis_2 fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
neuroinflammation_3["neuroinflammation"] -->|"affects"| oligodendrocytes["oligodendrocytes"]
style neuroinflammation_3 fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
unfolded_protein_response["unfolded protein response"] -->|"active in"| oligodendrocytes["oligodendrocytes"]
style unfolded_protein_response fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
aging["aging"] -->|"affects"| oligodendrocytes["oligodendrocytes"]
style aging fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
style oligodendrocytes fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| ds-f2c28aed24a7 | provides_data_for | dataset | 1.00 |
| myelin | produces | protein | 0.90 |
| multiple sclerosis | associated_with | disease | 0.90 |
| sphingolipid metabolism | active_in | pathway | 0.85 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | involved_in | disease | 0.85 |
| multiple sclerosis | activates | disease | 0.80 |
| multiple sclerosis | inhibits | disease | 0.80 |
| neurodegeneration | associated_with | disease | 0.80 |
| NEUROINFLAMMATION | drives | process | 0.80 |
| neurodegeneration | drives | process | 0.80 |
| demyelination | implicated_in | process | 0.80 |
| unfolded protein response | active_in | pathway | 0.75 |
| neuroinflammation | activates | phenotype | 0.72 |
| neurodegeneration | activates | phenotype | 0.72 |
| multiple sclerosis | interacts_with | disease | 0.70 |
| multiple sclerosis | expressed_in | disease | 0.70 |
| multiple sclerosis | causes | disease | 0.70 |
| myelin_breakdown | vulnerable_to | pathology | 0.70 |
| oxidative stress response | active_in | pathway | 0.65 |
| autophagic alterations | associated_with | phenotype | 0.65 |
| myelin dysfunction | involved_in | biological_process | 0.60 |
| Parkinson's disease | causes | disease | 0.60 |
| neurodegeneration | causes | disease | 0.60 |
| neuroinflammation | causes | disease | 0.60 |
| Parkinson's disease | activates | disease | 0.60 |
| neurodegeneration | protects_against | disease | 0.60 |
| Parkinson's disease | expressed_in | disease | 0.60 |
| phagocytosis | activates | process | 0.60 |
| phagocytosis | expressed_in | process | 0.60 |
| ferroptosis | activates | process | 0.60 |
| ALS | associated_with | disease | 0.60 |
| amyloid aggregation | interacts_with | process | 0.60 |
| multiple sclerosis | regulates | disease | 0.60 |
| cholesterol homeostasis | active_in | pathway | 0.55 |
| neurotrophin signaling | active_in | pathway | 0.55 |
| synaptic plasticity | active_in | pathway | 0.55 |
| lipid metabolism | active_in | pathway | 0.55 |
| epigenetic regulation | active_in | pathway | 0.55 |
| insulin signaling | active_in | pathway | 0.55 |
| senescence | active_in | pathway | 0.55 |
| autophagy pathway | active_in | pathway | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| ds-f2c28aed24a7 | data_in | dataset | 1.00 |
| neurodegeneration | affects | disease | 0.90 |
| multiple sclerosis | affects | disease | 0.90 |
| neuroinflammation | affects | disease | 0.90 |
| unfolded protein response | active_in | pathway | 0.90 |
| aging | affects | disease | 0.90 |
| Alzheimer's disease | affects | disease | 0.90 |
| lipid metabolism | active_in | pathway | 0.90 |
| MOG | expressed_in | gene | 0.90 |
| SMS2 | expressed_in | gene | 0.90 |
| FERROPTOSIS | affects | process | 0.90 |
| axon | found_in | organelle | 0.90 |
| GPR37 | expressed_in | gene | 0.88 |
| OxPC | causes | chemical | 0.80 |
| complement cascade | active_in | pathway | 0.80 |
| Parkinson's disease | affects | disease | 0.80 |
| RNA | expressed_in | gene | 0.80 |
| SGMS1 | associated_with | gene | 0.80 |
| SGMS1 | regulates | gene | 0.80 |
| SGMS1 | implicated_in | gene | 0.80 |
| NLRP3 | activates | gene | 0.80 |
| pyroptosis | active_in | pathway | 0.80 |
| NLRP3 | regulates | gene | 0.80 |
| AQP4 | expressed_in | gene | 0.80 |
| MBP | expressed_in | gene | 0.80 |
| BIN1 | expressed_in | gene | 0.80 |
| NLRP3 | expressed_in | gene | 0.80 |
| SMPD1 | expressed_in | gene | 0.80 |
| Piezo1 | regulates | gene | 0.80 |
| DYNAMIN1 | associated_with | gene | 0.70 |
| MOG | biomarker_for | gene | 0.70 |
| AQP4 | activates | gene | 0.70 |
| epilepsy | affects | disease | 0.70 |
| GPR37 | inhibits | gene | 0.70 |
| GPR37 | protects_against | gene | 0.70 |
| LDLR | associated_with | gene | 0.70 |
| NF-kB signaling | active_in | pathway | 0.70 |
| glioblastoma | affects | disease | 0.70 |
| ferroptosis | active_in | pathway | 0.70 |
| RNA | activates | gene | 0.70 |
| PI3K-AKT-mTOR signaling | active_in | pathway | 0.70 |
| SGMS1 | expressed_in | gene | 0.70 |
| SMPD1 | associated_with | gene | 0.70 |
| SMPD1 | regulates | gene | 0.70 |
| frontotemporal dementia | affects | disease | 0.70 |
| ALS | affects | disease | 0.70 |
| MOG | associated_with | gene | 0.70 |
| MOG | causes | gene | 0.70 |
| C3 | expressed_in | gene | 0.70 |
| LDLR | expressed_in | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| PDE4 Inhibition as Inflammatory Reset for PD Oligodendrocyte | 0.576 | neuroinflammation | How do oligodendrocytes initiate neuroin |
| ACSL4-Ferroptotic Priming in Stressed Oligodendrocytes Drive | 0.512 | Alzheimer's Disease | Cell type vulnerability in Alzheimers Di |
| ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligo | 0.493 | Alzheimer's Disease | Cell type vulnerability in Alzheimers Di |
| ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes v | 0.491 | Alzheimer's Disease | Cell type vulnerability in Alzheimers Di |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.505
neuroinflammation | 2026-04-13 | 2 hypotheses Top: 0.505
neuroinflammation | 2026-04-13 | 2 hypotheses Top: 0.632
neurodegeneration | 2026-04-11 | 0 hypotheses
neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.529
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Vitamin C inhibits ACSL4 to alleviate ferro-aging in primates. [PMID:41819088] | Liu L, Zheng Z, You W, Yang P, Wen Y et | Cell Metab | 2026 | 0 |
| [The Chinese medicine Gandouling attenuates brain injury in hepatolenticular deg [PMID:41946579] | Wu K, Wang N, Zhao D, Wei W, Zhang W et | Zhejiang Da Xue Xue Bao Yi Xue | 2026 | 0 |
| Vitamin C slows primate aging by targeting iron-driven lipid peroxidation. [PMID:41950897] | Yu PL, Xu CR | Cell Metab | 2026 | 0 |
| The IL-33/ST2 Signaling Axis Alleviates Splenic Injury in Severe Acute Pancreati [PMID:41954769] | Cui L, Xu N, Chen J, Bin C, Feng Y et al | Pancreas | 2026 | 0 |
| Fibroblast-Specific GPX4 Deletion Exacerbates IBD via Lipid Peroxidation. [PMID:41955120] | Zhang Y, Ying Y, Huang W, Rosenfeld ZA, | Am J Physiol Gastrointest Live | 2026 | 0 |
| Isorhamnetin-preconditioned MSC-derived exosomes restore ovarian function by inh [PMID:41947243] | Zhang Q, Yu J, Zheng Y, Jiang J, Zheng L | Stem Cell Res Ther | 2026 | 0 |